Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Early Phase 1:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Early Phase 1
1 (25.0%)Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2017-06-22
- Last Posted Date
- 2017-06-23
- Lead Sponsor
- Mikkel Christensen
- Target Recruit Count
- 10
- Registration Number
- NCT03195257
Liraglutide in Spinal Fluid
Not Applicable
Completed
- Conditions
- Liraglutide Blood-brain Transfer
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2014-04-04
- Lead Sponsor
- Mikkel Christensen
- Target Recruit Count
- 8
- Registration Number
- NCT02104037
- Locations
- 🇩🇰
Diabetes Research Division, Department of Medicine, Hellerup, Denmark
GIP and GLP-1 in Type 1 Diabetes
Not Applicable
Completed
- Conditions
- Hypoglycemia
- First Posted Date
- 2012-12-03
- Last Posted Date
- 2015-07-13
- Lead Sponsor
- Mikkel Christensen
- Target Recruit Count
- 10
- Registration Number
- NCT01739283
- Locations
- 🇩🇰
Gentofte Hospital, Hellerup, Denmark
GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes
Early Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2013-04-02
- Lead Sponsor
- Mikkel Christensen
- Target Recruit Count
- 12
- Registration Number
- NCT01414556
- Locations
- 🇩🇰
Gentofte Hospital, Hellerup, Denmark
News
No news found